Northwest & Ethical Investments L.P. Purchases 1,053 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Northwest & Ethical Investments L.P. increased its stake in Intuitive Surgical, Inc. by 6.6%, owning 16,977 shares worth $8.41 million as of the latest filing with the SEC.
• Several institutional investors also significantly increased their stakes in Intuitive Surgical, with 83.64% of the stock currently held by institutional investors.
• Analysts have raised target prices for Intuitive Surgical, with UBS Group setting a new target of $585 and multiple firms assigning a "buy" rating, indicating positive outlooks for the company.

Northwest & Ethical Investments L.P. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,977 shares of the medical equipment provider's stock after buying an additional 1,053 shares during the quarter. Northwest & Ethical Investments L.P.'s holdings in Intuitive Surgical were worth $8,406,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Brighton Jones LLC lifted its stake in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after acquiring an additional 731 shares during the last quarter. Bank Pictet & Cie Europe AG grew its stake in Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after buying an additional 883 shares during the last quarter. Commerce Bank grew its stake in Intuitive Surgical by 1.3% during the 4th quarter. Commerce Bank now owns 15,610 shares of the medical equipment provider's stock valued at $8,148,000 after purchasing an additional 199 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S grew its stake in Intuitive Surgical by 71.1% during the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 38,537 shares of the medical equipment provider's stock valued at $20,115,000 after purchasing an additional 16,020 shares during the last quarter. Finally, MML Investors Services LLC boosted its stake in shares of Intuitive Surgical by 0.4% in the fourth quarter. MML Investors Services LLC now owns 63,181 shares of the medical equipment provider's stock worth $32,978,000 after buying an additional 228 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,839 shares of company stock valued at $7,896,972 over the last quarter. Insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Up 0.3%

Shares of NASDAQ:ISRG traded up $1.25 during trading on Wednesday, hitting $480.45. 1,409,146 shares of the stock were exchanged, compared to its average volume of 2,142,699. The company has a fifty day moving average price of $506.84 and a two-hundred day moving average price of $523.82. The company has a market cap of $172.23 billion, a PE ratio of 67.01, a P/E/G ratio of 5.02 and a beta of 1.59. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the firm posted $1.78 EPS. Intuitive Surgical's revenue was up 21.4% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ISRG. Barclays reduced their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Evercore ISI increased their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday. Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, BTIG Research increased their price target on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.